$SGRY
Surgery Partners, Inc. Stock $sgry

$sgry Overview Financials Valuation SEC Filings Company Website

2021 Q2 Form 10-Q Financial Statement

#000163883321000136 Filed on August 04, 2021

Income Statement

Concept	2021 Q2	2020 Q2
Revenue	$543.3M	$374.7M
YoY Change	45.0%	-15.87%
Cost Of Revenue	$402.4M	$297.8M
YoY Change	35.12%	-12.51%
Gross Profit	$140.9M	$76.90M
YoY Change	83.22%	-26.76%
Gross Profit Margin	25.93%	20.52%
Selling, General & Admin	$47.10M	$46.80M
YoY Change	0.64%	5.64%
% of Gross Profit	33.43%	60.86%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$25.20M	$23.40M
YoY Change	7.69%	22.51%
% of Gross Profit	17.89%	30.43%
Operating Expenses	$483.8M	$330.0M
YoY Change	46.61%	-15.36%
Operating Profit	$59.50M	$44.70M
YoY Change	33.11%	-19.46%
Interest Expense	-$53.40M	-$49.20M
YoY Change	8.54%	6.03%
% of Operating Profit	-89.75%	-110.07%
Other Income/Expense, Net		$200.0K
YoY Change		-50.0%
Pretax Income	$6.100M	-$4.500M
YoY Change	-235.56%	-149.45%
Income Tax	-$2.700M	-$600.0K
% Of Pretax Income	-44.26%
Net Earnings	-$26.90M	-$32.50M
YoY Change	-17.23%	64.14%
Net Earnings / Revenue	-4.95%	-8.67%
Basic Earnings Per Share	-$0.39	-$0.86
Diluted Earnings Per Share	-$0.39	-$0.86
COMMON SHARES
Basic Shares Outstanding	69.27M shares	48.84M shares
Diluted Shares Outstanding	69.27M shares	48.84M shares

Balance Sheet

Concept	2021 Q2	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$464.8M	$326.3M
YoY Change	42.45%	177.94%
Cash & Equivalents	$464.8M	$326.3M
Short-Term Investments
Other Short-Term Assets	$27.60M	$37.00M
YoY Change	-25.41%	-33.57%
Inventory	$57.30M	$49.00M
Prepaid Expenses	$28.30M	$23.30M
Receivables	$374.9M	$310.9M
Other Receivables	$0.00	$8.200M
Total Short-Term Assets	$952.9M	$746.5M
YoY Change	27.65%	41.12%
LONG-TERM ASSETS
Property, Plant & Equipment	$862.7M	$816.0M
YoY Change	5.72%	19.11%
Goodwill	$3.488B	$3.409B
YoY Change	2.32%	0.19%
Intangibles
YoY Change
Long-Term Investments	$90.50M	$91.40M
YoY Change	-0.98%	-2.45%
Other Assets	$51.10M	$21.70M
YoY Change	135.48%	-93.07%
Total Long-Term Assets	$4.668B	$4.498B
YoY Change	3.77%	3.12%
TOTAL ASSETS
Total Short-Term Assets	$952.9M	$746.5M
Total Long-Term Assets	$4.668B	$4.498B
Total Assets	$5.621B	$5.245B
YoY Change	7.17%	7.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$109.1M	$104.7M
YoY Change	4.2%	46.03%
Accrued Expenses	$200.7M	$258.6M
YoY Change	-22.39%	16.33%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$69.60M	$63.50M
YoY Change	9.61%	10.82%
Total Short-Term Liabilities	$531.9M	$571.2M
YoY Change	-6.88%	54.88%
LONG-TERM LIABILITIES
Long-Term Debt	$2.786B	$2.623B
YoY Change	6.24%	9.39%
Other Long-Term Liabilities	$151.7M	$127.3M
YoY Change	19.17%	-67.11%
Total Long-Term Liabilities	$151.7M	$127.3M
YoY Change	19.17%	-67.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$531.9M	$571.2M
Total Long-Term Liabilities	$151.7M	$127.3M
Total Liabilities	$683.6M	$698.5M
YoY Change	-2.13%	-7.59%
SHAREHOLDERS EQUITY
Retained Earnings	-$479.7M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$765.1M	$204.4M
YoY Change
Total Liabilities & Shareholders Equity	$5.621B	$5.245B
YoY Change	7.17%	7.23%

Cashflow Statement

Concept	2021 Q2	2020 Q2
OPERATING ACTIVITIES
Net Income	-$26.90M	-$32.50M
YoY Change	-17.23%	64.14%
Depreciation, Depletion And Amortization	$25.20M	$23.40M
YoY Change	7.69%	22.51%
Cash From Operating Activities	$2.300M	$181.9M
YoY Change	-98.74%	581.27%
INVESTING ACTIVITIES
Capital Expenditures	-$13.50M	-$8.100M
YoY Change	66.67%	-59.5%
Acquisitions
YoY Change
Other Investing Activities	-$12.90M	-$6.700M
YoY Change	92.54%	48.89%
Cash From Investing Activities	-$26.40M	-$14.80M
YoY Change	78.38%	-39.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-53.00M	-35.40M
YoY Change	49.72%	29.67%
NET CHANGE
Cash From Operating Activities	2.300M	181.9M
Cash From Investing Activities	-26.40M	-14.80M
Cash From Financing Activities	-53.00M	-35.40M
Net Change In Cash	-77.10M	131.7M
YoY Change	-158.54%	-624.7%
FREE CASH FLOW
Cash From Operating Activities	$2.300M	$181.9M
Capital Expenditures	-$13.50M	-$8.100M
Free Cash Flow	$15.80M	$190.0M
YoY Change	-91.68%	306.85%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001638833
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	City Area Code CityAreaCode	615
	dei	Local Phone Number LocalPhoneNumber	234-5900
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	37027
	dei	Document Period End Date DocumentPeriodEndDate	2021-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-37576
	dei	Entity Registrant Name EntityRegistrantName	Surgery Partners, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3620923
	dei	Entity Address Address Line1 EntityAddressAddressLine1	310 Seven Springs Way, Suite 500
	dei	Entity Address City Or Town EntityAddressCityOrTown	Brentwood
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TN
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
	dei	Trading Symbol TradingSymbol	SGRY
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	82478580	shares
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	464800000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	317900000	USD
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	374900000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	382200000	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	57300000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	56400000	USD
CY2021Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	28300000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	17600000	USD
CY2021Q2	us-gaap	Other Assets Current OtherAssetsCurrent	27600000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	27400000	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	952900000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	801500000	USD
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	231000000.0	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	189300000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net Excluding Capital Leased Assets PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets	543900000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net Excluding Capital Leased Assets PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets	544600000	USD
CY2021Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	3533900000	USD
CY2020Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	3514900000	USD
CY2021Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	90200000	USD
CY2020Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	90300000	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	318800000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	310100000	USD
CY2021Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	129800000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	124800000	USD
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	51100000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	27000000.0	USD
CY2021Q2	us-gaap	Assets Assets	5620600000	USD
CY2020Q4	us-gaap	Assets Assets	5413200000	USD
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	109100000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	100200000	USD
CY2021Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	75600000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	65400000	USD
CY2021Q2	sgry	Medicare Accelerated Payments And Deferred Governmental Grants Current MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent	78600000	USD
CY2020Q4	sgry	Medicare Accelerated Payments And Deferred Governmental Grants Current MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent	109800000	USD
CY2021Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	199000000.0	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	217000000.0	USD
CY2021Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	69600000	USD
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	64400000	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	531900000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	556800000	USD
CY2021Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2786100000	USD
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2792400000	USD
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	310800000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	300900000	USD
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	151700000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	139700000	USD
CY2021Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	312800000	USD
CY2020Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	310000	shares
CY2020Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	306800000	USD
CY2020Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	310000	shares
CY2021Q2	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	310000	shares
CY2021Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q2	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	310000	shares
CY2021Q2	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Redemption Value RedeemableNoncontrollingInterestEquityPreferredRedemptionValue	0	USD
CY2020Q4	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Redemption Value RedeemableNoncontrollingInterestEquityPreferredRedemptionValue	434500000	USD
CY2021Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	434500000	USD
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	82478580	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82478580	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50461706	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50461706	shares
CY2021Q2	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	800000	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-479700000	USD
CY2020Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	500000	USD
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1298400000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	607900000	USD
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-54400000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-61000000.0	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-431800000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	765100000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	115600000	USD
CY2021Q2	us-gaap	Minority Interest MinorityInterest	762200000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	766500000	USD
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1527300000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	882100000	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5620600000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5413200000	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	543300000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	374700000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1055700000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	815700000	USD
CY2021Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	155300000	USD
CY2020Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	116100000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	307000000.0	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	256500000	USD
CY2021Q2	us-gaap	Supplies Expense SuppliesExpense	157500000	USD
CY2020Q2	us-gaap	Supplies Expense SuppliesExpense	110100000	USD
	us-gaap	Supplies Expense SuppliesExpense	304800000	USD
	us-gaap	Supplies Expense SuppliesExpense	239400000	USD
CY2021Q2	us-gaap	Professional Fees ProfessionalFees	57400000	USD
CY2020Q2	us-gaap	Professional Fees ProfessionalFees	45300000	USD
	us-gaap	Professional Fees ProfessionalFees	112900000	USD
	us-gaap	Professional Fees ProfessionalFees	92100000	USD
CY2021Q2	sgry	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	22600000	USD
CY2020Q2	sgry	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	21500000	USD
	sgry	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	42800000	USD
CY2021Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	32200000	USD
CY2020Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	26300000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	63800000	USD
	sgry	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	45400000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	54700000	USD
CY2021Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	425000000.0	USD
CY2020Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	319300000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	833900000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	685500000	USD
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24500000	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25300000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	51300000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	48100000	USD
CY2021Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	25200000	USD
CY2020Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	23400000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	50900000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	45200000	USD
CY2021Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3000000.0	USD
CY2020Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2500000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	5600000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	4500000	USD
CY2021Q2	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-1000000.0	USD
CY2020Q2	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-2900000	USD
	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-100000	USD
	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-6400000	USD
CY2021Q2	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	9200000	USD
CY2020Q2	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	4900000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	14500000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	10400000	USD
CY2021Q2	sgry	Grant Revenue GrantRevenue	4900000	USD
CY2020Q2	sgry	Grant Revenue GrantRevenue	43100000	USD
	sgry	Grant Revenue GrantRevenue	20000000.0	USD
	sgry	Grant Revenue GrantRevenue	43100000	USD
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-9600000	USD
CY2020Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-9600000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
CY2020Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-1200000	USD
CY2021Q2	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	-2800000	USD
CY2020Q2	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	-200000	USD
	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	-2800000	USD
	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	-1700000	USD
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	483800000	USD
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	330000000.0	USD
	us-gaap	Operating Expenses OperatingExpenses	931900000	USD
	us-gaap	Operating Expenses OperatingExpenses	747500000	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	59500000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	44700000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	123800000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	68200000	USD
CY2021Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-53400000	USD
CY2020Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-49200000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-106700000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-96300000	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	6100000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-4500000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	17100000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-28100000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2700000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-600000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2500000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15800000	USD
CY2021Q2	us-gaap	Profit Loss ProfitLoss	8800000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	-3900000	USD
	us-gaap	Profit Loss ProfitLoss	19600000	USD
	us-gaap	Profit Loss ProfitLoss	-12300000	USD
CY2021Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	35700000	USD
CY2020Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	28600000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	67500000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	47700000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-26900000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-32500000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-47900000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-60000000.0	USD
CY2021Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2020Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	9700000	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	10300000	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	19200000	USD
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26900000	USD
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-42200000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-58200000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-79200000	USD
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.86
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.94
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.63
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.86
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.94
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.63
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69267000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48840000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62060000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48661000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69267000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48840000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62060000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48661000	shares
CY2021Q2	us-gaap	Profit Loss ProfitLoss	8800000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	-3900000	USD
	us-gaap	Profit Loss ProfitLoss	19600000	USD
	us-gaap	Profit Loss ProfitLoss	-12300000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	200000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	7300000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	6600000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-17900000	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	9000000.0	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	3400000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	26200000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-30200000	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	35700000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	28600000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	67500000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	47700000	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-26700000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25200000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-41300000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-77900000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	983400000	USD
CY2020Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-13900000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2800000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	9500000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-25200000	USD
CY2020Q1	sgry	Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet	700000	USD
CY2020Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	14900000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	923400000	USD
CY2020Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-9700000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3800000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	9700000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	7300000	USD
CY2020Q2	sgry	Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet	1700000	USD
CY2020Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	20900000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	895900000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	882100000	USD
CY2021Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	100000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-2800000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	10300000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	248300000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	6400000	USD
CY2021Q1	sgry	Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet	2300000	USD
CY2021Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	20800000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1105300000	USD
CY2021Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-4900000	USD
CY2021Q2	sgry	Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet	5600000	USD
CY2021Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	22300000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3700000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	439700000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	200000	USD
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1527300000	USD
	us-gaap	Profit Loss ProfitLoss	19600000	USD
	us-gaap	Profit Loss ProfitLoss	-12300000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	50900000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	45200000	USD
	sgry	Noncash Interest Income Expense Net NoncashInterestIncomeExpenseNet	-5700000	USD
	sgry	Noncash Interest Income Expense Net NoncashInterestIncomeExpenseNet	-2200000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	9300000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6900000	USD
	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-100000	USD
	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-6400000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-9600000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3200000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-16400000	USD
	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	400000	USD
	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	200000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	20000000.0	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	20100000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3100000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-16300000	USD
	sgry	Increase Decrease In Medicare Accelerated Payments And Deferred Governmental Grants IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants	-28800000	USD
	sgry	Increase Decrease In Medicare Accelerated Payments And Deferred Governmental Grants IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants	124700000	USD
	sgry	Increase Decrease In Settlement Payments IncreaseDecreaseInSettlementPayments	32200000	USD
	sgry	Increase Decrease In Settlement Payments IncreaseDecreaseInSettlementPayments	4000000.0	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-5000000.0	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-22200000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	52500000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	211100000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	28000000.0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19900000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	15200000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	12400000	USD
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	2500000	USD
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	9400000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-400000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-40700000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-22500000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	309400000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	182800000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	283100000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	288200000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	8700000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	6500000	USD
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	2400000	USD
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	260900000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	12700000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	5100000	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	0	USD
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	63400000	USD
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	51700000	USD
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	3400000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	1900000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-10900000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-300000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	134800000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	45000000.0	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	146600000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	233600000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	318200000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	93000000.0	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	464800000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	326600000	USD
CY2021Q2	sgry	Grant Revenue GrantRevenue	4900000	USD
	sgry	Grant Revenue GrantRevenue	20000000.0	USD
CY2020	sgry	Coronavirus Aid Reliefand Economic Security Act Cares Act Government Grant Received Accelerated Payments CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments	120000000	USD
CY2021Q2	sgry	Number Of Surgical Facilities Owned NumberOfSurgicalFacilitiesOwned	123	surgical_facility
CY2021Q2	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	30	state
CY2021Q2	sgry	Number Of Surgical Facilities Owned Majority Interest NumberOfSurgicalFacilitiesOwnedMajorityInterest	87	surgical_facility
CY2021Q2	sgry	Number Of Surgical Facilities Owned Consolidated NumberOfSurgicalFacilitiesOwnedConsolidated	106	surgical_facility
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Reclassifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain reclassifications have been made to the comparative periods' financial statements to conform to the current year presentation.</span></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.</span></div>
	sgry	Proceeds From Government Assistance ProceedsFromGovernmentAssistance	67000000	USD
CY2021Q2	sgry	Proceeds From Government Assistance ProceedsFromGovernmentAssistance	1000000	USD
	sgry	Proceeds From Government Assistance ProceedsFromGovernmentAssistance	8000000	USD
	sgry	Coronavirus Aid Relief And Economic Security Act Cares Act Government Grant Received Repayments CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments	20000000	USD
CY2021Q2	sgry	Coronavirus Aid Relief And Economic Security Act Cares Act Government Grants Deferred Accelerated Payments CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments	76000000	USD
CY2020Q4	sgry	Coronavirus Aid Relief And Economic Security Act Cares Act Government Grants Deferred Accelerated Payments CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments	95000000	USD
CY2021Q2	sgry	Deferred Employee Related Liabilities Current DeferredEmployeeRelatedLiabilitiesCurrent	16900000	USD
CY2020Q4	sgry	Deferred Employee Related Liabilities Current DeferredEmployeeRelatedLiabilitiesCurrent	16900000	USD
CY2021Q2	sgry	Variable Interest Entity Number Of Facilities VariableInterestEntityNumberOfFacilities	3	surgical_facility
CY2021Q2	sgry	Variable Interest Entity Number Of Facilities VariableInterestEntityNumberOfFacilities	2	physician_practice
CY2021Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	543300000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	374700000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1055700000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	815700000	USD
CY2020Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	300000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	3468000000.0	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	20200000	USD
	sgry	Goodwill Written Off Related To Sale Of Business Unit And Deconsolidation GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation	100000	USD
CY2021Q2	us-gaap	Goodwill Goodwill	3488100000	USD
CY2020Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	306800000	USD
CY2019Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	321000000.0	USD
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	24400000	USD
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	11300000	USD
	sgry	Redeemable Noncontrolling Interest Increase Decrease From Redemptions Or Purchase Of Interests RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests	1900000	USD
	sgry	Redeemable Noncontrolling Interest Increase Decrease From Redemptions Or Purchase Of Interests RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests	-1700000	USD
	sgry	Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	20300000	USD
	sgry	Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	15900000	USD
CY2021Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	312800000	USD
CY2020Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	314700000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.146
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.562
	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-4100000	USD
	us-gaap	Income Tax Reconciliation Disposition Of Business IncomeTaxReconciliationDispositionOfBusiness	-3000000.0	USD
	sgry	Effective Income Tax Rate Reconciliation Coronavirus Aid Relief And Economic Security Act Cares Act And Tax Settlement Amount EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityActCARESActAndTaxSettlementAmount	-11900000	USD
CY2021Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	281700000	USD
CY2020Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	281200000	USD
CY2021Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	16800000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	16300000	USD
CY2021Q2	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	2855700000	USD
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	2856800000	USD
CY2021Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	69600000	USD
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	64400000	USD
CY2021Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2786100000	USD
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2792400000	USD
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-9600000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-9600000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	37500000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	36300000	USD
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	13800000	USD
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	12000000.0	USD
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	12600000	USD
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	10400000	USD
	sgry	Finance Lease Cost FinanceLeaseCost	26400000	USD
	sgry	Finance Lease Cost FinanceLeaseCost	22400000	USD
	sgry	Variable And Short Term Lease Cost VariableAndShortTermLeaseCost	9800000	USD
	sgry	Variable And Short Term Lease Cost VariableAndShortTermLeaseCost	8300000	USD
	us-gaap	Lease Cost LeaseCost	73700000	USD
	us-gaap	Lease Cost LeaseCost	67000000.0	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	36700000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	33700000	USD
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	11900000	USD
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	10400000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	10600000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	8300000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	31400000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	37500000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	6600000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	8500000	USD
	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	5100000	USD
	us-gaap	Reclassifications Of Temporary To Permanent Equity ReclassificationsOfTemporaryToPermanentEquity	439700000	USD
	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	-25800000	USD
CY2021Q2	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	1200000000.0	USD
CY2020Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	1200000000.0	USD
CY2021Q2	us-gaap	Derivative Asset Notional Amount DerivativeAssetNotionalAmount	17600000	USD
CY2021Q2	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	72800000	USD
CY2020Q4	us-gaap	Derivative Asset Notional Amount DerivativeAssetNotionalAmount	0	USD
CY2020Q4	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	61000000.0	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax	3200000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax	3200000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-26900000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-32500000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-47900000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-60000000.0	USD
CY2021Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2020Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	9700000	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	10300000	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	19200000	USD
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26900000	USD
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-42200000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-58200000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-79200000	USD
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69267000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69267000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48840000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48840000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62060000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62060000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48661000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48661000	shares
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.86
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.86
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.94
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.94
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.63
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.63
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	30.25
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	39100000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	39200000	USD
CY2021Q2	us-gaap	Litigation Reserve Current LitigationReserveCurrent	0	USD
CY2020Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	32200000	USD
CY2021Q2	us-gaap	Interest Payable Current InterestPayableCurrent	29600000	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	24500000	USD
CY2021Q2	sgry	Tax Receivable Agreement Liability Current TaxReceivableAgreementLiabilityCurrent	21200000	USD
CY2020Q4	sgry	Tax Receivable Agreement Liability Current TaxReceivableAgreementLiabilityCurrent	21200000	USD
CY2021Q2	srt	Payables To Customers PayablesToCustomers	22200000	USD
CY2020Q4	srt	Payables To Customers PayablesToCustomers	20900000	USD
CY2021Q2	sgry	Cost Report Liabilities Current CostReportLiabilitiesCurrent	30500000	USD
CY2020Q4	sgry	Cost Report Liabilities Current CostReportLiabilitiesCurrent	16900000	USD
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	56400000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	62100000	USD
CY2021Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	199000000.0	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	217000000.0	USD
CY2021Q2	us-gaap	Self Insurance Reserve SelfInsuranceReserve	23200000	USD
CY2020Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	21400000	USD
CY2021Q2	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	10500000	USD
CY2020Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	10500000	USD
CY2021Q2	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	30700000	USD
CY2018	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-46000000.0	USD
CY2020Q1	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-1200000	USD
	sgry	Collaborative Tax Agreement Projected Tax Savings Term CollaborativeTaxAgreementProjectedTaxSavingsTerm	P5Y
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.24
CY2021Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	43200000	USD
CY2020Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	43200000	USD
CY2021Q2	sgry	Deferred Income Tax Liabilities Net Of Discount DeferredIncomeTaxLiabilitiesNetOfDiscount	38900000	USD
CY2020Q4	sgry	Deferred Income Tax Liabilities Net Of Discount DeferredIncomeTaxLiabilitiesNetOfDiscount	37000000.0	USD
CY2020Q4	sgry	Deferred Income Tax Liabilities Net Of Discount Current DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent	21200000	USD
CY2021Q2	sgry	Deferred Income Tax Liabilities Net Of Discount Current DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent	21200000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2021Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	543300000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	374700000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1055700000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	815700000	USD
CY2021Q2	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	75900000	USD
CY2020Q2	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	58200000	USD
	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	148800000	USD
	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	104700000	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	6100000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-4500000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	17100000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-28100000	USD
CY2021Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	35700000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-1200000	USD
CY2020Q2	sgry	Business Combination Gain Loss On Acquisition Escrow BusinessCombinationGainLossOnAcquisitionEscrow	0	USD
CY2020Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	28600000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	67500000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	47700000	USD
CY2021Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	25200000	USD
CY2020Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	23400000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	50900000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	45200000	USD
CY2021Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-53400000	USD
CY2020Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-49200000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-106700000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-96300000	USD
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	4100000	USD
CY2020Q2	us-gaap	Share Based Compensation ShareBasedCompensation	3400000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	9300000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6900000	USD
CY2021Q2	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	11400000	USD
CY2020Q2	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	10100000	USD
	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	20800000	USD
	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	22700000	USD
CY2021Q2	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-1000000.0	USD
CY2020Q2	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-2900000	USD
	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-100000	USD
	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-6400000	USD
CY2021Q2	sgry	Gain Loss Relatedto Litigation Settlement And Other Litigation Costs GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts	-800000	USD
CY2020Q2	sgry	Gain Loss Relatedto Litigation Settlement And Other Litigation Costs GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts	-2300000	USD
	sgry	Gain Loss Relatedto Litigation Settlement And Other Litigation Costs GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts	-1800000	USD
	sgry	Gain Loss Relatedto Litigation Settlement And Other Litigation Costs GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts	-3800000	USD
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-9600000	USD
CY2020Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-9600000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021Q2	sgry	Business Combination Gain Loss On Acquisition Escrow BusinessCombinationGainLossOnAcquisitionEscrow	0	USD
	sgry	Business Combination Gain Loss On Acquisition Escrow BusinessCombinationGainLossOnAcquisitionEscrow	0	USD
	sgry	Business Combination Gain Loss On Acquisition Escrow BusinessCombinationGainLossOnAcquisitionEscrow	800000	USD
CY2021Q2	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	75900000	USD
CY2020Q2	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	58200000	USD
	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	148800000	USD
	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	104700000	USD
CY2021Q2	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	9200000	USD
CY2020Q2	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	4900000	USD
CY2021Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2200000	USD
CY2020Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	5200000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	14500000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	10400000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	6300000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	12300000	USD
CY2021Q2	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	800000	USD
CY2020Q2	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	2300000	USD
	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	1800000	USD
	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	2600000	USD
CY2021Q2	us-gaap	Assets Assets	5620600000	USD
CY2020Q4	us-gaap	Assets Assets	5413200000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	28000000.0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19900000	USD

Files In Submission

Name	View Source	Status
0001638833-21-000136-index-headers.html	Edgar Link	pending
0001638833-21-000136-index.html	Edgar Link	pending
0001638833-21-000136.txt	Edgar Link	pending
0001638833-21-000136-xbrl.zip	Edgar Link	pending
a2021q2exhibit102.htm	Edgar Link	pending
a2021q2exhibit311.htm	Edgar Link	pending
a2021q2exhibit312.htm	Edgar Link	pending
a2021q2exhibit321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sgry-20210630.htm	Edgar Link	pending
sgry-20210630.xsd	Edgar Link	pending
sgry-20210630_cal.xml	Edgar Link	unprocessable
sgry-20210630_def.xml	Edgar Link	unprocessable
sgry-20210630_htm.xml	Edgar Link	completed
sgry-20210630_lab.xml	Edgar Link	unprocessable
sgry-20210630_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SGRY
Surgery Partners, Inc. Stock $sgry

2021 Q2 Form 10-Q Financial Statement

#000163883321000136 Filed on August 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGRY Surgery Partners, Inc. Stock $sgry

2021 Q2 Form 10-Q Financial Statement

#000163883321000136 Filed on August 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGRY
Surgery Partners, Inc. Stock $sgry